ipamorelin subcutaneous or intramuscular CJC-1295 + Ipamorelin Peptide Therapy:

Ward PS, Patel J, Wise DR, Abdel-Wahab O, Bennett BD, Coller HA, Cross JR, Fantin VR, Hedvat CV, Perl AE, Rabinowitz JD, Carroll M, Su SM, Sharp KA, Levine RL, Thompson CB

Akaike, T., Ida, T., Wei, F

Peptide therapy may be explored by adults experiencing: Age-related hormone decline Difficulty recovering from workouts Poor sleep quality Low energy Stubborn body fat Difficulty maintaining lean muscle Wellness optimization goals The right peptide depends heavily on the individuals goals, medical history, lifestyle, and lab evaluation

Non-alcoholic fatty kidney disease (NAFKD): a novel disease that explains the etiology of hyperuricemia and gout in metabolic syndrome